The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Asian Multicenter Prospective Study of ctDNA Sequencing
Official Title: Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing: A-TRAIN
Study ID: NCT05099978
Brief Summary: This study is a genetic analysis of aberrations in circulating tumor DNA (ctDNA) in patients in Asian countries. This study protocol is divided into parts describing several subanalyses that differ in terms of cancer types, analytical methods, participating countries, and participating institutions.
Detailed Description: NGS analysis will be performed on cfDNA extracted from peripheral blood samples of target patients to determine the types and incidences of genetic abnormalities. Patient information and gene abnormality data will be integrated, and the types and incidences of gene abnormalities by cancer type will be analyzed.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
National Cancer Center Hospital, Tokyo, , Japan
Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of
Sarawak General Hospital, Kuching, Sarawak, Malaysia
University Malaya Medicine Centre, Kuala Lumpur, Selangor, Malaysia
Hospital Kuala Lumpur, Kuala Lumpur, , Malaysia
Institut Kanser Negara, Putrajaya, , Malaysia
St. Luke's Medical Center, Manila, , Philippines
National Cancer Centre of Singapore, Bukit Merah, , Singapore
National University Hopital, Kent Ridge, , Singapore
National Taiwan University Hospital, Taipei, Zhongzheng Dist, Taiwan
Vajira Hospital, Bangkok, , Thailand
Chulalongkorn University, Bangkok, , Thailand
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, , Thailand
Phramongkutklao Hospital, Bangkok, , Thailand
Mahidol University by Faculty of Medicine, Siriraj Hospital, Bangkok, , Thailand
Chiang Mai University, Chiang Mai, , Thailand
Songklanagarind Hospital, Songkhla, , Thailand
K Hospital, Hanoi, , Vietnam
Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, , Vietnam
Name: Kan Yonemori, MD, PhD
Affiliation: Department of Medical Oncology, National Cancer Cancer Hospital
Role: PRINCIPAL_INVESTIGATOR